Azitra (AZTR) Invested Capital (2023 - 2026)
Azitra's (AZTR) quarterly Invested Capital came in at $5850.0 in Q1 2026, down 73.77% YoY from $22299.0 in Q1 2025, and down 42.14% on a QoQ basis from $10111.0 in Q4 2025.
Azitra (AZTR) Invested Capital (2023 - 2026) Analysis & Trends
Azitra (AZTR) has 4 years of Invested Capital data on file, last reported at $5850.0 in Q1 2026.
- Quarterly Invested Capital fell 73.77% year-over-year to $5850.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48565.0 (down 56.66% YoY) and the FY2025 annual result came in at $10111.0, down 61.36% from the prior year.
- Invested Capital slipped to $5850.0 in Q1 2026, from $10111.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $44206.0 in Q3 2023 to a low of $5850.0 in Q1 2026.
- A 4-year average of $25714.4 and a median of $26170.0 in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2024 — Invested Capital plunged 32.24% — and 2026, when it sank 73.77%.
- Tracing AZTR's Invested Capital over 4 years: stood at $40769.0 in 2023, then plunged by 35.81% to $26170.0 in 2024, then slumped by 61.36% to $10111.0 in 2025, then sank by 42.14% to $5850.0 in 2026.
- The last three Invested Capital figures came in at $5850.0 (Q1 2026), $10111.0 (Q4 2025), and $14271.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Azitra | 2.53 Mn | 2.53 Mn | - | 1,486.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,486.00 |
| Mar 31, 2026 | 5,850.00 |
| Dec 31, 2025 | 10,111.00 |
| Sep 30, 2025 | 14,271.00 |
| Jun 30, 2025 | 18,333.00 |
| Mar 31, 2025 | 22,299.00 |
| Dec 31, 2024 | 26,170.00 |
| Sep 30, 2024 | 29,953.00 |
| Jun 30, 2024 | 33,646.00 |
| Mar 31, 2024 | 37,250.00 |
| Dec 31, 2023 | 40,769.00 |
| Sep 30, 2023 | 44,206.00 |